ZNF623 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.602200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.998200E-01
Normal-vs-Stage2
7.537600E-01
Normal-vs-Stage3
1.523600E-01
Normal-vs-Stage4
6.101400E-01
Stage1-vs-Stage2
7.516000E-01
Stage1-vs-Stage3
3.184000E-03
Stage1-vs-Stage4
5.235600E-01
Stage2-vs-Stage3
5.87890000000035E-05
Stage2-vs-Stage4
4.504800E-01
Stage3-vs-Stage4
1.756960E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.613000E-01
Normal-vs-AfricanAmerican
6.685800E-01
Normal-vs-Asian
5.543000E-01
Caucasian-vs-AfricanAmerican
8.717000E-01
Caucasian-vs-Asian
5.484400E-01
AfricanAmerican-vs-Asian
7.950600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.817600E-01
Normal-vs-Female
7.462000E-01
Male-vs-Female
8.236200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.143400E-01
Normal-vs-Age(41-60Yrs)
8.812000E-01
Normal-vs-Age(61-80Yrs)
5.815200E-01
Normal-vs-Age(81-100Yrs)
5.714400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.511000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.387200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.105800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.744490E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.158600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.773400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.525800E-01
Normal-vs-Daily Drinker
4.673800E-01
Normal-vs-Weekly Drinker
5.694200E-01
Normal-vs-Occasional Drinker
8.033200E-01
Normal-vs-Social Drinker
8.633800E-01
Non Drinker-vs-Daily Drinker
6.975200E-01
Non Drinker-vs-Weekly Drinker
9.673400E-01
Non Drinker-vs-Occasional Drinker
1.646360E-01
Non Drinker-vs-Social Drinker
4.768200E-01
Daily Drinker-vs-Weekly Drinker
7.467800E-01
Daily Drinker-vs-Occasional Drinker
7.557500E-02
Daily Drinker-vs-Social Drinker
2.322400E-01
Weekly Drinker-vs-Occasional Drinker
1.857370E-01
Weekly Drinker-vs-Social Drinker
4.112800E-01
Occasional Drinker-vs-Social Drinker
4.592800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.452820E-01
Normal-vs-Grade 2
3.279800E-02
Normal-vs-Grade 3
5.299700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.378400E-01
Grade 1-vs-Grade 3
7.980400E-02
Grade 1-vs-Grade 4
1.452820E-01
Grade 2-vs-Grade 3
5.747700E-02
Grade 2-vs-Grade 4
3.279800E-02
Grade 3-vs-Grade 4
5.299700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.090800E-01
Normal-vs-NonDiabetic
7.312400E-01
Diabetic-vs-NonDiabetic
2.646400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.507200E-01
Normal-vs-NoPancreatitis
7.167600E-01
Pancreatitis-vs-NoPancreatitis
9.126800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.784000E-01
Normal-vs-N1
7.779000E-01
N0-vs-N1
9.168200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.378800E-01
Normal-vs-TP53-NonMutant
7.801800E-01
TP53-Mutant-vs-TP53-NonMutant
1.019690E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
